Ontario Psychiatric Association Psychotherapy Conference 2021

Psychotherapy conference: the cost-effectiveness of psychodynamic psychotherapy, the patients who need it, and obstacles to its provision

Psychodynamic therapy, including psychoanalysis, is often undervalued by policy makers. Data substantiating its efficacy, effectiveness, cost-effectiveness and frequent cost-offsets are all too often ignored or dismissed along with the sequelae if it is unavailable to those who most benefit from it.

Despite pressures for non-medical practitioners to be the sole providers of psychotherapy, there is a crucial place for psychiatrists to be not merely diagnosticians but also the only psychotherapists who have the training to make a fuller ongoing differential diagnosis of medical contributors to their patients’ mental illness.

Date: Saturday, October 2, 2021

Time: 1:00 - 3:00 p.m. EDT

Learn more and register now

Learning objectives

Attendees should learn, in detail:

  • the cost-effectiveness research data to support the need for extended dynamic psychotherapy
  • the cohort of patients who need it preferentially over less intensive treatments
  • the obstacles to its provision primarily by inaccurate insurance “medically appropriate” guidelines that overlook the necessity for extended psychodynamic therapy and psychoanalysis.


Dr. Susan G. Lazar has presented and published widely on the cost-effectiveness of psychotherapy, including the special place for psychodynamic therapy, in book chapters and articles. Dr. Lazar served as a consultant to The Mental Health Work Group of The White House Task Force for Health Care Reform in the Clinton administration. She is a Supervising and Training Analyst at The Washington Baltimore Psychoanalytic Society, a Clinical Professor of Psychiatry at The George Washington University School of Medicine and Distinguished Life Fellow of the American Psychiatric Association.

Abonnez-vous à notre bulletin